Recruiting soon

Complication Rates of Central Venous vs Midline Catheters in Hospitalized Adults

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Ultrasound Guided Central Venous Catheter

+ Ultrasound Guided Midline Catheter

Device
Who is being recruted

Over 18 Years
+3 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Supportive Care Study

Interventional
Study Start: February 2026
See protocol details

Summary

Principal SponsorAlbert Einstein College of Medicine
Study ContactAriella S Gartenberg, MDMore contacts
Last updated: February 5, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 1, 2026

Actual date on which the first participant was enrolled.

This study aims to compare complication rates between two types of catheters used in hospitals: central venous catheters (CVCs) and midline catheters. Every year, millions of these catheters are used in the United States, and they can sometimes lead to infections or other issues like blood clots. While some alternatives like peripherally inserted central catheters (PICCs) have been tried, they also come with risks. Midline catheters, which don't extend as far into the body as CVCs or PICCs, have shown promise in reducing these complications. This research seeks to learn more about the safety and effectiveness of CVCs compared to midline catheters, as no large-scale studies have been conducted on this topic before. The trial will take place at a single urban academic center, involving adult patients who require certain medical support. These patients will be randomly assigned to receive either a CVC or a midline catheter. The study will last for a year, and the decision to participate will be made in the emergency department, where a clinician will discuss the trial with the patient. If the patient agrees, they will sign a consent form before the catheter is placed. The goal is to gather information on the rates of complications like infections or blood clots associated with each type of catheter, as well as any potential differences in patient outcomes.

Official TitleComplication Rates Associated With Central Venous Catheters Versus Midline Catheters: A Randomized Control Trial
NCT06884176
Principal SponsorAlbert Einstein College of Medicine
Study ContactAriella S Gartenberg, MDMore contacts
Last updated: February 5, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

100 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

2 inclusion criteria required to participate
Patients over 18 years of age being treated in the Emergency Department at Jacobi Medical Center

Have an upper extremity (left or right arm) that can accept a midline catheter

1 exclusion criteria prevent from participating
The patient is known or is suspected to be allergic to materials contained in the device

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
If randomized to this group, patients will receive a triple lumen central venous catheter

Group II

Active Comparator
If randomized to this group, patients will receive a single lumen midline catheter

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Jacobi Medical Center

The Bronx, United StatesOpen Jacobi Medical Center in Google Maps
Recruiting soonOne Study Center